Role of locoregional therapies in the wake of systemic therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2019.09.023
Abstract: Multiple systemic agents have recently been approved in the first- and second-line setting for hepatocellular carcinoma (HCC), increasing the therapeutic options for patients and treating physicians. The randomised controlled trials that led to these approvals… read more here.
Keywords: systemic therapy; systemic agents; role locoregional; locoregional therapies ... See more keywords